SS Innovations InternationalSSII -4.06%46 Debt-to-Equity is 0.25 as of Mar. 2026, which is 4% above its 10-year median of 0.24. GuruFocus rates SSII with a GF Score™ of 46/100 and a GF Value™ of $18.64 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 705 Medical Devices & Instruments companies, SS Innovations International ranks worse than 52.34% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for SS Innovations International's Debt-to-Equity or its related term are showing as below:
SSII'
s Debt-to-Equity Range Over the Past 10 Years
Min: -3.09 Med: 0.24 Max: 14.41
Current: 0.25
During the past 10 years, the highest Debt-to-Equity Ratio of SS Innovations International was 14.41. The lowest was -3.09. And the median was 0.24.
SSII's Debt-to-Equity is ranked worse than 52.34% of 705
companies
in the Medical Devices & Instruments industry
Industry Median: 0.23
vs SSII: 0.25
SS Innovations International (NAS:SSII) Debt-to-Equity Explanation
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
SS Innovations International Debt-to-Equity Related Terms
SS Innovations International Debt-to-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SSII vs BVS, TCMD, BBNX: Debt-to-Equity Comparison
For the Medical Devices subindustry, SS Innovations International's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SS Innovations International Debt-to-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SS Innovations International's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where SS Innovations International's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SS Innovations International (SSII) has a Debt-to-Equity of 0.25 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on SS Innovations International and its competitors. This is near median its historical median of 0.24. According to the industry distribution chart, SS Innovations International ranks #369 out of 705 companies in the Medical Devices & Instruments industry, placing it in the top 52.3%.
Is SS Innovations International's Debt-to-Equity too high?
SS Innovations International's current Debt-to-Equity of 0.25 is near median its 10-year median of 0.24. The Medical Devices & Instruments industry median Debt-to-Equity is 0.23. SS Innovations International's value of 0.25 is 8.7% above this industry median. Based on the distribution chart, SS Innovations International ranks #369 out of 705 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, SS Innovations International has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SS Innovations International's Debt-to-Equity compare to BVS and TCMD?
According to the Medical Devices & Instruments industry distribution chart, SS Innovations International ranks #369 out of 705 companies for Debt-to-Equity. This places SS Innovations International in the lower half of its industry. The industry median Debt-to-Equity is 0.23. SS Innovations International's value of 0.25 is 8.7% above this benchmark. While the company's 10-year median is 0.24 vs. the industry median of 0.23, SS Innovations International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.23, based on 705 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SS Innovations International's current Debt-to-Equity of 0.25 is 8.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on SS Innovations International and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SS Innovations International's current Debt-to-Equity is 0.25, which is near median its own 10-year median of 0.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SS Innovations International stock overvalued right now?
Based on GuruFocus' analysis, SS Innovations International (SSII) is currently considered Possible Value Trap. The stock's GF Value™ is $18.64, compared to a current price of $3.79 — trading 79.7% below its estimated fair value. The current Debt-to-Equity is 0.25, which is near median its 10-year median of 0.24 and 8.7% above the Medical Devices & Instruments industry median of 0.23. SS Innovations International's overall GF Score™ is 46/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For SS Innovations International (SSII), the current Debt-to-Equity is 0.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SS Innovations International (SSII) Overvalued in 2026?
Based on GuruFocus' analysis, SS Innovations International stock appears to be undervalued.
The current stock price of $3.79 is trading 79.7% below its estimated GF Value™ of $18.64.
GuruFocus considers SS Innovations International to be Possible Value Trap.
Key valuation signals for SSII:
Debt-to-Equity: 0.25 (near median its 10-year median of 0.24)
GF Value™: $18.64 vs. price of $3.79 (79.7% below fair value)
Industry Position: 8.7% above the Medical Devices & Instruments median (#369 of 705)
No single metric tells the full story. See the SSII stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SS Innovations International Inc is a commercial-stage surgical robotics company. It designs, manufactures, and markets a surgical robotic system called the SSi Mantra Surgical Robotic System (the SSi Mantra) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic, and cardiac surgeries. Additionally, the company offers a suite of stapling, energy, and core instrumentation for its surgical systems, under the brand name of SSi Mudra.
46GF Score
Get the complete analysis for SSII
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SSII has been successfully added to your 
